Aclarion, Inc. (ACON)
| Previous Close | 0.7981 |
| Open | 0.7711 |
| Bid | 0.7700 x 4000 |
| Ask | 0.8000 x 800 |
| Day's Range | 0.7700 - 0.7855 |
| 52 Week Range | 0.7510 - 4.0500 |
| Volume | |
| Avg. Volume | 59,490 |
| Market Cap | 6.026M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -7.1200 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.00 |
- Simply Wall St.
Aclarion Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS Lags
Aclarion ( NASDAQ:ACON ) Third Quarter 2022 Results Key Financial Results Net loss: US$1.63m (loss widened by 90% from...
- ACCESSWIRE
Aclarion, Inc. Releases Updated Investor Presentation In Connection with Appearance at LD Micro Main Event XV
/ Aclarion, Inc. (NASDAQ:ACON)(NASDAQ:ACONW) ("Aclarion" or the "Company"), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain (CLBP), will be presenting at the 15th annual LD Micro Main Event on Tuesday, October 25th at 9:00 AM PT at the Luxe Sunset Boulevard Hotel in Los Angeles.
- ACCESSWIRE
Dr. Sigurd Berven to join Aclarion as a Key Opinion Leader Surgeon Advisor
Aclarion, Inc., ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, announced today that Sigurd Berven M.D., Chief of Spine Service, Orthopaedic Surgery at University of California at San Francisco will advise the company as a key opinion leader (KOL) nationally.
